Warren completed his PhD – CO2 photoreduction kinetics: an experimental and numerical approach – under the supervision of Prof. Mercedes Maroto-Valer. He has experience leading teams for the development of active pharmaceutical ingredient processes that include international collaborations with a technology transfer with Merck pharmaceuticals, process development for Cerbios-Pharma and a safety study for the Bill and Melinda Gates Foundation. Through academic and industrial experience, he has developed statistical and numerical expertise for scientiﬁc and engineering decision making. Warren recently joined the XChem group at Diamond Light Source. He will be working on developing user interfaces and making automated synthesis robotics accessible to chemists/non-chemists.